X-18564526-GATATATATATATAT-GATATATATATATATATATAT
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS1
The ENST00000623535.2(CDKL5):c.145+4_145+5insATATAT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 19)
Exomes 𝑓: 0.000057 ( 0 hom. 0 hem. )
Consequence
CDKL5
ENST00000623535.2 splice_region, intron
ENST00000623535.2 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.405
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant X-18564526-G-GATATAT is Benign according to our data. Variant chrX-18564526-G-GATATAT is described in ClinVar as [Likely_benign]. Clinvar id is 1615526.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000566 (29/512819) while in subpopulation MID AF= 0.0005 (1/2001). AF 95% confidence interval is 0.0000422. There are 0 homozygotes in gnomad4_exome. There are 0 alleles in male gnomad4_exome subpopulation. Median coverage is 5. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.145+23_145+28dupATATAT | intron_variant | Intron 4 of 17 | ENST00000623535.2 | NP_001310218.1 | ||
CDKL5 | NM_001037343.2 | c.145+23_145+28dupATATAT | intron_variant | Intron 5 of 21 | NP_001032420.1 | |||
CDKL5 | NM_003159.3 | c.145+23_145+28dupATATAT | intron_variant | Intron 4 of 20 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 19
GnomAD3 genomes
Cov.:
19
GnomAD4 exome AF: 0.0000566 AC: 29AN: 512819Hom.: 0 Cov.: 5 AF XY: 0.00 AC XY: 0AN XY: 125309
GnomAD4 exome
AF:
AC:
29
AN:
512819
Hom.:
Cov.:
5
AF XY:
AC XY:
0
AN XY:
125309
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 19
GnomAD4 genome
Cov.:
19
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Jan 05, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at